Copyright
©2013 Baishideng.
World J Radiol. Mar 28, 2013; 5(3): 126-142
Published online Mar 28, 2013. doi: 10.4329/wjr.v5.i3.126
Published online Mar 28, 2013. doi: 10.4329/wjr.v5.i3.126
Figure 8 A computed tomography image of a 45-year-old man with clear cell type renal cell carcinoma who had received pre-operative Sorafenib.
An exophytic heterogeneously hyperenhanced right renal mass (A) demonstrated homogenous hypoenhancement after the targeted therapy (B). Note an atypical segment 6 hepatic hemangioma and a L1 bone island.
- Citation: Peungjesada S, Chuang HH, Prasad SR, Choi H, Loyer EM, Bronstein Y. Evaluation of cancer treatment in the abdomen: Trends and advances. World J Radiol 2013; 5(3): 126-142
- URL: https://www.wjgnet.com/1949-8470/full/v5/i3/126.htm
- DOI: https://dx.doi.org/10.4329/wjr.v5.i3.126